PRKN and Parkinson disease: In contrast, one group demonstrated that isradipine was not protective in iPSC-derived dopaminergic neurons from PD patients with Parkin mutations, showing instead that elevated expression and activity of T-type Ca2+ channels are more deleterious for this pathogenic genotype [174].